» Articles » PMID: 3155492

Isozymic Composition and Regulatory Properties of Phosphofructokinase from Well-differentiated and Anaplastic Medullary Thyroid Carcinomas of the Rat

Overview
Journal Cancer Res
Specialty Oncology
Date 1985 Jan 1
PMID 3155492
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Acceleration of glycolysis is, in general, a characteristic of neoplasia. Previous studies have shown that this increase in glycolysis is achieved by quantitative increases in the activities of the key regulatory enzymes, hexokinase, phosphofructokinase (PFK) and/or pyruvate kinase, which are often accompanied by isozymic alterations that facilitate glycolysis. In this study, we investigated the alterations in the activity, isozymic profile, and kinetic-regulatory properties of PFK from the medullary thyroid carcinomas of the rat, which represent a model for the neuroectodermally derived tumors in humans. Contrary to the expected, we found that undifferentiated tumors showed a decrease in the enzyme activity as compared to the highly differentiated tumors. This decrease in PFK activity was accompanied by an increase in the expression of the liver-type isozyme of PFK. The enzymes from the 2 tumor types showed no significant differences in their affinity and cooperativity toward the substrates, fructose 6-phosphate and adenosine triphosphate (ATP). However, the tumor PFKs showed major differences with respect to their behavior toward the allosteric regulators of the enzymes, ATP, citrate, and fructose 2,6-diphosphate; the latter is a recently discovered activator of the enzyme. The enzyme from the undifferentiated tumor was less sensitive to citrate inhibition, which was more readily reversed by cyclic adenosine 3':5'-monophosphate. In addition, it was less sensitive to ATP inhibition at low fructose 6-phosphate concentrations. More importantly, the enzyme from the undifferentiated tumors was more sensitive to the activation by fructose 2,6-diphosphate especially when inhibited by citrate and ATP. The altered regulatory properties of the enzyme from the undifferentiated tumors most probably reflect its altered isozymic composition, i.e., increase in the liver-type isozyme. The preferential expression of the liver-type isozyme by undifferentiated and rapidly replicating cancer cells may be explained in terms of the unique regulatory properties of this isozyme. Although the concentrations of fructose 2,6-diphosphate were comparable in these 2 tumor types, the higher sensitivity of the liver-type PFK to activation by this compound may permit accelerated glycolytic flux observed in undifferentiated tumors, despite a decrease in total PFK activity.

Citing Articles

Interleukin -1β Promotes Lung Adenocarcinoma Growth and Invasion Through Promoting Glycolysis via p38 Pathway.

Tan Q, Duan L, Huang Q, Chen W, Yang Z, Chen J J Inflamm Res. 2021; 14:6491-6509.

PMID: 34880649 PMC: 8648110. DOI: 10.2147/JIR.S319433.


MiR-302 Regulates Glycolysis to Control Cell-Cycle during Neural Tube Closure.

Keuls R, Kojima K, Lozzi B, Steele J, Chen Q, Gross S Int J Mol Sci. 2020; 21(20).

PMID: 33066028 PMC: 7589003. DOI: 10.3390/ijms21207534.


Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress.

Kim N, Cha Y, Lee J, Lee S, Yang J, Yun J Nat Commun. 2017; 8:14374.

PMID: 28176759 PMC: 5309788. DOI: 10.1038/ncomms14374.


The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.

Wang J, Zhang P, Zhong J, Tan M, Ge J, Tao L Oncotarget. 2016; 7(19):27142-57.

PMID: 27049827 PMC: 5053638. DOI: 10.18632/oncotarget.8382.


Ubiquitous presence of gluconeogenic regulatory enzyme, fructose-1,6-bisphosphatase, within layers of rat retina.

Mamczur P, Mazurek J, Rakus D Cell Tissue Res. 2010; 341(2):213-21.

PMID: 20614135 PMC: 2914254. DOI: 10.1007/s00441-010-1008-2.